0.010904 0.006295 0.000000 0.000000 0.012591 0.000000 0.000000 0.000000 0.011872 0.00000 0.00000 0.00000 Boyington, J.C. Riaz, A.N. Patamawenu, A. Coligan, J.E. Brooks, A.G. Sun, P.D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 12 90.00 90.00 120.00 91.710 91.710 84.230 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Immunity IUNIEH 2048 1074-7613 10 75 82 10.1016/S1074-7613(00)80008-4 10023772 Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors. 1999 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100 1 IMAGE PLATE 1998-01 MARRESEARCH M x-ray 1 0.9795 1.0 X9B NSLS 0.9795 SYNCHROTRON NSLS BEAMLINE X9B 15004.530 CD94 C-TYPE LECTIN DOMAIN 1 man polymer 18.015 water 39 nat water no no LQKDSDCCSCQEKWVGYRCNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDELDFMSSSQQFYWIGLSYSEEHTAWLWE NGSALSQYLFPSFETFNTKNCIAYNPNGNALDESCEDKNRYICKQQLI LQKDSDCCSCQEKWVGYRCNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDELDFMSSSQQFYWIGLSYSEEHTAWLWE NGSALSQYLFPSFETFNTKNCIAYNPNGNALDESCEDKNRYICKQQLI A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia Escherichia coli sample NATURAL KILLER CELL CELL SURFACE 9606 Homo sapiens INCLUSION BODIES 511693 Escherichia coli BL21 BL21 PLASMID MODIFIED PET30 1 3.4 63.7 7.5 pH 7.5 repository Initial release Version format compliance Version format compliance 1 0 1999-06-15 1 1 2008-03-24 1 2 2011-07-13 Y BNL 1999-01-14 REL HOH water HOH 1 2 HOH HOH 1 A HOH 2 2 HOH HOH 2 A HOH 3 2 HOH HOH 3 A HOH 4 2 HOH HOH 4 A HOH 5 2 HOH HOH 5 A HOH 6 2 HOH HOH 6 A HOH 7 2 HOH HOH 7 A HOH 8 2 HOH HOH 8 A HOH 9 2 HOH HOH 9 A HOH 10 2 HOH HOH 10 A HOH 11 2 HOH HOH 11 A HOH 12 2 HOH HOH 12 A HOH 13 2 HOH HOH 13 A HOH 14 2 HOH HOH 14 A HOH 15 2 HOH HOH 15 A HOH 16 2 HOH HOH 16 A HOH 17 2 HOH HOH 17 A HOH 18 2 HOH HOH 18 A HOH 19 2 HOH HOH 19 A HOH 20 2 HOH HOH 20 A HOH 21 2 HOH HOH 21 A HOH 22 2 HOH HOH 22 A HOH 23 2 HOH HOH 23 A HOH 24 2 HOH HOH 24 A HOH 25 2 HOH HOH 25 A HOH 26 2 HOH HOH 26 A HOH 27 2 HOH HOH 27 A HOH 28 2 HOH HOH 28 A HOH 29 2 HOH HOH 29 A HOH 30 2 HOH HOH 30 A HOH 31 2 HOH HOH 31 A HOH 32 2 HOH HOH 32 A HOH 33 2 HOH HOH 33 A HOH 34 2 HOH HOH 34 A HOH 35 2 HOH HOH 35 A HOH 36 2 HOH HOH 36 A HOH 37 2 HOH HOH 37 A HOH 38 2 HOH HOH 38 A HOH 39 2 HOH HOH 39 A n 1 52 A n 2 53 A n 3 54 A n 4 55 A n 5 56 A n 6 57 A n 7 58 A CYS 59 n 8 CYS 59 A SER 60 n 9 SER 60 A CYS 61 n 10 CYS 61 A GLN 62 n 11 GLN 62 A GLU 63 n 12 GLU 63 A LYS 64 n 13 LYS 64 A TRP 65 n 14 TRP 65 A VAL 66 n 15 VAL 66 A GLY 67 n 16 GLY 67 A TYR 68 n 17 TYR 68 A ARG 69 n 18 ARG 69 A CYS 70 n 19 CYS 70 A ASN 71 n 20 ASN 71 A CYS 72 n 21 CYS 72 A TYR 73 n 22 TYR 73 A PHE 74 n 23 PHE 74 A ILE 75 n 24 ILE 75 A SER 76 n 25 SER 76 A SER 77 n 26 SER 77 A GLU 78 n 27 GLU 78 A GLN 79 n 28 GLN 79 A LYS 80 n 29 LYS 80 A THR 81 n 30 THR 81 A TRP 82 n 31 TRP 82 A ASN 83 n 32 ASN 83 A GLU 84 n 33 GLU 84 A SER 85 n 34 SER 85 A ARG 86 n 35 ARG 86 A HIS 87 n 36 HIS 87 A LEU 88 n 37 LEU 88 A CYS 89 n 38 CYS 89 A ALA 90 n 39 ALA 90 A SER 91 n 40 SER 91 A GLN 92 n 41 GLN 92 A LYS 93 n 42 LYS 93 A SER 94 n 43 SER 94 A SER 95 n 44 SER 95 A LEU 96 n 45 LEU 96 A LEU 97 n 46 LEU 97 A GLN 98 n 47 GLN 98 A LEU 99 n 48 LEU 99 A GLN 100 n 49 GLN 100 A ASN 101 n 50 ASN 101 A THR 102 n 51 THR 102 A ASP 103 n 52 ASP 103 A GLU 104 n 53 GLU 104 A LEU 105 n 54 LEU 105 A ASP 106 n 55 ASP 106 A PHE 107 n 56 PHE 107 A MET 108 n 57 MET 108 A SER 109 n 58 SER 109 A SER 110 n 59 SER 110 A SER 111 n 60 SER 111 A GLN 112 n 61 GLN 112 A GLN 113 n 62 GLN 113 A PHE 114 n 63 PHE 114 A TYR 115 n 64 TYR 115 A TRP 116 n 65 TRP 116 A ILE 117 n 66 ILE 117 A GLY 118 n 67 GLY 118 A LEU 119 n 68 LEU 119 A SER 120 n 69 SER 120 A TYR 121 n 70 TYR 121 A SER 122 n 71 SER 122 A GLU 123 n 72 GLU 123 A GLU 124 n 73 GLU 124 A HIS 125 n 74 HIS 125 A THR 126 n 75 THR 126 A ALA 127 n 76 ALA 127 A TRP 128 n 77 TRP 128 A LEU 129 n 78 LEU 129 A TRP 130 n 79 TRP 130 A GLU 131 n 80 GLU 131 A ASN 132 n 81 ASN 132 A GLY 133 n 82 GLY 133 A SER 134 n 83 SER 134 A ALA 135 n 84 ALA 135 A LEU 136 n 85 LEU 136 A SER 137 n 86 SER 137 A GLN 138 n 87 GLN 138 A TYR 139 n 88 TYR 139 A LEU 140 n 89 LEU 140 A PHE 141 n 90 PHE 141 A PRO 142 n 91 PRO 142 A SER 143 n 92 SER 143 A PHE 144 n 93 PHE 144 A GLU 145 n 94 GLU 145 A THR 146 n 95 THR 146 A PHE 147 n 96 PHE 147 A ASN 148 n 97 ASN 148 A THR 149 n 98 THR 149 A LYS 150 n 99 LYS 150 A ASN 151 n 100 ASN 151 A CYS 152 n 101 CYS 152 A ILE 153 n 102 ILE 153 A ALA 154 n 103 ALA 154 A TYR 155 n 104 TYR 155 A ASN 156 n 105 ASN 156 A PRO 157 n 106 PRO 157 A ASN 158 n 107 ASN 158 A GLY 159 n 108 GLY 159 A ASN 160 n 109 ASN 160 A ALA 161 n 110 ALA 161 A LEU 162 n 111 LEU 162 A ASP 163 n 112 ASP 163 A GLU 164 n 113 GLU 164 A SER 165 n 114 SER 165 A CYS 166 n 115 CYS 166 A GLU 167 n 116 GLU 167 A ASP 168 n 117 ASP 168 A LYS 169 n 118 LYS 169 A ASN 170 n 119 ASN 170 A ARG 171 n 120 ARG 171 A TYR 172 n 121 TYR 172 A ILE 173 n 122 ILE 173 A CYS 174 n 123 CYS 174 A LYS 175 n 124 LYS 175 A GLN 176 n 125 GLN 176 A GLN 177 n 126 GLN 177 A LEU 178 n 127 LEU 178 A ILE 179 n 128 ILE 179 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A LEU 52 A LEU 1 1 Y 1 A GLN 53 A GLN 2 1 Y 1 A LYS 54 A LYS 3 1 Y 1 A ASP 55 A ASP 4 1 Y 1 A SER 56 A SER 5 1 Y 1 A ASP 57 A ASP 6 1 Y 1 A CYS 58 A CYS 7 1 Y 1 A GLU 63 -27.45 -115.12 1 A LYS 64 -69.75 46.77 1 A LYS 93 48.82 29.04 1 A SER 94 -129.14 -154.41 1 A SER 95 -173.55 143.52 1 A LEU 96 -43.17 92.32 1 A LEU 97 1.28 117.57 1 A ASN 101 160.38 152.03 1 A ASP 103 -98.93 44.55 1 A MET 108 -58.62 3.35 1 A SER 109 -10.23 -36.00 1 A SER 111 -17.78 109.86 1 A GLN 112 -84.10 38.00 1 A THR 126 28.09 72.88 1 A LEU 140 -64.23 -88.76 1 A SER 143 -35.54 -33.89 1 A PHE 144 13.03 -96.08 1 A GLU 145 -34.35 -20.80 1 A PHE 147 -25.40 108.34 1 A THR 149 -31.13 -16.77 1 A SER 165 -29.56 125.06 1 A CYS 166 -57.66 -4.94 PROTEIN_REP.PARAM TOPHCSDX.PRO PARAM11.WAT TOPH11.WAT 40.6 -18.587 -10.633 0.000 -18.587 0.000 10.638 BULK SOLVENT CORRECTION DURING REFINEMENT 0.322 0.019 0.22 0.22 2.60 8.00 279 5667 4.9 86.4 RANDOM 1000000.00 0.01 1 RESTRAINED THROUGHOUT 2.0 MIRAS 2.60 8.00 39 1036 0 0 997 0.009 1.6 27.9 0.75 1.9 1.5 3.2 2.0 2.6 2.0 3.9 2.5 0.348 2.7 387 10 62.9 2.6 20.0 1B6E 6450 0.0 0.063 1 12.5 4.8 94.5 2.6 2.7 0.301 91.7 data reduction DENZO data scaling SCALEPACK model building X-PLOR 3.851 refinement X-PLOR 3.851 phasing X-PLOR 3.851 CD94 HUMAN CD94 1 N N 2 N N A TRP 82 A TRP 31 HELX_P A SER 91 A SER 40 1 H1 10 disulf 2.036 A CYS 59 A SG CYS 8 1_555 A CYS 70 A SG CYS 19 1_555 disulf 2.025 A CYS 61 A SG CYS 10 1_555 A CYS 72 A SG CYS 21 1_555 disulf 2.027 A CYS 89 A SG CYS 38 1_555 A CYS 174 A SG CYS 123 1_555 disulf 2.026 A CYS 152 A SG CYS 101 1_555 A CYS 166 A SG CYS 115 1_555 NK CELL NK CELL, RECEPTOR, C-TYPE LECTIN, C-TYPE LECTIN-LIKE, NKD KLRD1_HUMAN UNP 1 1 Q13241 MAVFKTTLWRLISGTLGIICLSLMATLGILLKNSFTKLSIEPAFTPGPNIELQKDSDCCSCQEKWVGYRCNCYFISSEQK TWNESRHLCASQKSSLLQLQNTDELDFMSSSQQFYWIGLSYSEEHTAWLWENGSALSQYLFPSFETFNTKNCIAYNPNGN ALDESCEDKNRYICKQQLI 52 179 1B6E 52 179 Q13241 A 1 1 128 3 4 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A VAL 66 A VAL 15 A TYR 68 A TYR 17 A ASN 71 A ASN 20 A ILE 75 A ILE 24 A ARG 171 A ARG 120 A GLN 176 A GLN 125 A ALA 127 A ALA 76 A LEU 129 A LEU 78 A TYR 115 A TYR 64 A SER 122 A SER 71 A ASN 151 A ASN 100 A TYR 155 A TYR 104 A ALA 161 A ALA 110 A SER 165 A SER 114 179 P 65 2 2